2. @Benzinga: JPM Securities Picks Through #Biotech News For Winners $INFI $IPXL $MNKD $VVUS $PCRX $PETX http://www.benzinga.com/analyst-ratings/analyst-color/15/02/5274351/jpm-securities-picks-through-biotech-news-for-winners

  3. JPM Securities Picks Through #Biotech News For Winners $INFI $IPXL $MNKD $VVUS $PCRX $PETX http://www.benzinga.com/analyst-ratings/analyst-color/15/02/5274351/jpm-securities-picks-through-biotech-news-for-winners

  4. $IPXL has 5 analyst ratings in the last 2 days. Median target: $46 (13% upside). View here: https://www.flashratings.com/stocks/1232-IPXL?src=stks&t=7

  5. $IPXL JMP lifts TP to $48 from $43. Maintains Market Outperform. Leerink ups to $43 from $30. JP Morgan ups to $40 from $38, keeps Neutral.

  6. Strong buy ratings issued for $IAG, $FDS, $IPXL, $CRZO, $HD more at www.tracour.com http://stocktwits.com/message/33141598

  7. $IPXL Earnings result is already out. Check out historical price reaction after ER. http://stocksearning.com/q.aspx?Sys=IPXL

  8. Finally, CEO explanations submitted in $IPXL earnings call transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/2944986-impaxs-ipxl-ceo-fred-wilkinson-on-q4-2014-results-earnings-call-transcript

  9. $IPXL Revenue and R&D Trends #CML http://lite.capitalmarketlabs.com/cmld3b/?shortcode=IPXL&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Research+and+Development+Expense/Revenue&start_date=01/01/2008&end_date=02/23/2015&sk=f32d4f5ccadb01110cad30a442e05edc

  10. $IPXL 4Q14 PR: To issue 2015 guidance after Tower Holdings /Lineage Therapeutics’ acquisition, anticipated to receiving FTC clearance soon.

  11. $IPXL 4Q14 PR: Global Pharmaceuticals, $117.9MM vs. $87MM and Impax Pharmaceuticals, $13.3MM vs. $13.8MM in 3Q14. http://stocktwits.com/message/33085216

  12. Impax Laboratories ($IPXL) PT Lifted to $49 at Guggenheim Post Q4 http://www.streetinsider.com/Analyst+Comments/Impax+Laboratories+%28IPXL%29+PT+Lifted+to+%2449+at+Guggenheim+Post+Q4/10305207.html?si_client=st

  13. Listen to $IPXL Q4 2014 earnings call - live at 08:30 AM, ondemand after - http://earningscast.com/q4-2014-impax-laboratories-inc-earnings-conference-call

  14. $IPXL beats the Estimize EPS Consensus by 1c and the Estimize Revenue Consensus by $4.15M - http://www.estimize.com/ipxl/fq4-2014?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

  15. $IPXL reports FQ4 earnings of 16c EPS and $131.21M Revs - http://www.estimize.com/ipxl/fq4-2014?utm_content=release_actuals&utm_medium=tweet&utm_source=stocktwits

  16. $IPXL Full year EPS UP 61% http://www.nasdaq.com/press-release/impax-revenues-increased-30-to-131-million-in-fourth-quarter-2014-20150224-00266

  17. $IPXL earnings..revs up 30%...

  18. Earnings before Tuesday’s open (Part 2) $DRH $DYAX $ECL $EXAS $EXLS $EXPD $FDML $GLDD $GTLS $HD $IART $IPXL $M $MNKD $NEO $ODP $PCRX $PF

  19. @OphirGottlieb: Shh. Biotech Unusual Option Vol data via --> https://secure.livevol.com/trial/livevol-x-trial/registration-promo-order-flow?offer_code=LV_OFlow $RIGL $STML $CTIC $PGNX $ZGNX $IPXL $ZIOP

  20. Shh. Biotech Unusual Option Volume data via --> https://secure.livevol.com/trial/livevol-x-trial/registration-promo-order-flow?offer_code=LV_OFlow $RIGL $STML $CTIC $PGNX $ZGNX $IPXL $ZIOP http://stocktwits.com/message/33057843

  21. $IPXL 3000 MAR15 $35 Cs traded vs. OI 3212 || looks like closing a position

  22. $IPXL ER on 2/24 Before Open. SP were UP 12 times out of last 19 qtrs (63%) in Earnings reactions http://stocksearning.com/q.aspx?Sys=IPXL

  23. remain long: stocks - $ACAD $AFFX $ALKS $BSX $EA $ENDP $HOLX $IPXL $ISIS $SIMO $TSRA ; etfs - $ASHR $EPHE $EPI $FV $NDX $IYR $VTI

  24. Monitoring $IPXL, $ISIS, $ARIA, $BOX, and NEON

  25. OrbiMed Advisors LLC just provided an update on its share ownership of Impax Laboratories http://www.conferencecalltranscripts.org/summary2/?id=1463516 $IPXL